These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2574230)

  • 21. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Science; 1983 Apr; 220(4596):530-2. PubMed ID: 6132447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.
    Mazière B; Loc'h C; Baron JC; Sgouropoulos P; Duquesnoy N; D'Antona R; Cambon H
    Eur J Pharmacol; 1985 Aug; 114(3):267-72. PubMed ID: 3877639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anosognosia in tardive dyskinesia: "tardive dysmentia" or "tardive dementia"?
    Myslobodsky MS
    Schizophr Bull; 1986; 12(1):1-6. PubMed ID: 2870563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
    Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
    Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan.
    Rizos EN; Chatziioannou S; Douzenis A; Siafakas N; Katsantoni E; Nikolaidou P; Papathanasiou M; Lykouras L
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):132-6. PubMed ID: 19740630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans.
    Cambon H; Baron JC; Boulenger JP; Loc'h C; Zarifian E; Maziere B
    Br J Psychiatry; 1987 Dec; 151():824-30. PubMed ID: 2901886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study.
    Silvestri S; Seeman MV; Negrete JC; Houle S; Shammi CM; Remington GJ; Kapur S; Zipursky RB; Wilson AA; Christensen BK; Seeman P
    Psychopharmacology (Berl); 2000 Oct; 152(2):174-80. PubMed ID: 11057521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.
    Crawley JC; Crow TJ; Johnstone EC; Oldland SR; Owen F; Owens DG; Smith T; Veall N; Zanelli GD
    Nucl Med Commun; 1986 Aug; 7(8):599-607. PubMed ID: 2946010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
    Miller R; Chouinard G
    Biol Psychiatry; 1993 Nov; 34(10):713-38. PubMed ID: 7904833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.
    Smith M; Wolf AP; Brodie JD; Arnett CD; Barouche F; Shiue CY; Fowler JS; Russell JA; MacGregor RR; Wolkin A
    Biol Psychiatry; 1988 Apr; 23(7):653-63. PubMed ID: 2967093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tardive dyskinesias].
    Mignot G
    Encephale; 1983; 9(2):151-66. PubMed ID: 6139271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 38. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms.
    Kornhuber J; Riederer P; Reynolds GP; Beckmann H; Jellinger K; Gabriel E
    J Neural Transm; 1989; 75(1):1-10. PubMed ID: 2563750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron-emission tomography in tardive dyskinesia.
    Pahl JJ; Mazziotta JC; Bartzokis G; Cummings J; Altschuler L; Mintz J; Marder SR; Phelps ME
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):457-65. PubMed ID: 8555748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.